Diabetes, metabolic syndrome and prostate cancer risk: Results from the EPICAP case-control study.

Lavalette, Céline; Cordina-Duverger, Emilie; Rébillard, Xavier; Lamy, Pierre-Jean; Trétarre, Brigitte; Cénée, Sylvie; Menegaux, Florence

Lavalette, Céline; Cordina-Duverger, Emilie; Rébillard, Xavier; Lamy, Pierre-Jean; Trétarre, Brigitte; Cénée, Sylvie; Menegaux, Florence.

Afiliación

Lavalette C; Université Paris-Saclay, UVSQ, Inserm, CESP, Exposome and Heredity Team, Villejuif, France.
Cordina-Duverger E; Université Paris-Saclay, UVSQ, Inserm, CESP, Exposome and Heredity Team, Villejuif, France.
Rébillard X; Service Urologie, Clinique Beau Soleil, Montpellier, France.
Lamy PJ; Service Urologie, Clinique Beau Soleil, Montpellier, France; Institut médical d'Analyse Génomique-Imagenome, Labosud, Montpellier, France.
Trétarre B; Registre des Tumeurs de l'Hérault, EA 2415, ICM, Montpellier, France.
Cénée S; Université Paris-Saclay, UVSQ, Inserm, CESP, Exposome and Heredity Team, Villejuif, France.
Menegaux F; Université Paris-Saclay, UVSQ, Inserm, CESP, Exposome and Heredity Team, Villejuif, France. Electronic address: Florence.menegaux@inserm.fr.

Cancer Epidemiol ; 81: 102281, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36279644

Palabras clave

Case-control study; Diabetes; Metabolic syndrome; NCEP-ATP III; Prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Epidemiol Asunto de la revista: EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google